RN LABORATORIES EUROPE BV
Overview
RN LABORATORIES EUROPE BV is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering CHLORHEXIDINE ACETATE ( 1,1-HEXAMETHYLENEBIS[5-(P-CHLOROPHENYL)BIGUANIDE] DIACETATE); CHLORHEXIDINE BASE (1,1'-HEXAMETHYLENEBIS[5-(4-CHLOROPHENYL) BIGUANIDE]); CHLORHEXIDINE HYDROCHLORIDE USP (2,4,11,13-TETRAAZATETRADECANEDIIMIDAMIDE, N,N”-BIS(4- CHLOROPHENYL)-3,12-DIIMINO-,DIHYDROCHLORIDE; 1,1’-HEXAMETHYLENEBIS[5-(PCHLOROPHENYL) BIGUANIDE]DIHYDROCHLORIDE); CLOBETASOL PROPIONATE USP (21-CHLORO-9-FLUORO-11, 17-DIHYDROXY-16-METHYLPREGNA-1,4-DIENE3,20-DIONE 17-PROPIONATE); N-octyl-1-[10-(4-octyliminopyridin-1-yl) decyl] pyridin-4-imine dihydrochloride (Octenidine Dihydrochloride); POVIDONE-IODINE USP (1-VINYL-2-PYRROLIDINONE POLYMER, COMPOUND WITH IODINE).
Core services & business areas
Active pharmaceutical ingredients supplied
Substances RN LABORATORIES EUROPE BV is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
RN LABORATORIES EUROPE BV holds 7 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- CLOBETASOL PROPIONATE USP (21-CHLORO-9-FLUORO-11, 17-DIHYDROXY-16-METHYLPREGNA-1,4-DIENE3,20-DIONE 17-PROPIONATE)Active2020-02-11
- STRONG CETRIMIDE 40% SOLUTION BP (HEXADECY(TRIMETHYL) AZANIUM BROMIDE (40% SOLUTION)Active2020-02-11
- CHLORHEXIDINE ACETATE ( 1,1-HEXAMETHYLENEBIS[5-(P-CHLOROPHENYL)BIGUANIDE] DIACETATE)Active2020-02-03
- CHLORHEXIDINE HYDROCHLORIDE USP (2,4,11,13-TETRAAZATETRADECANEDIIMIDAMIDE, N,N”-BIS(4- CHLOROPHENYL)-3,12-DIIMINO-,DIHYDROCHLORIDE; 1,1’-HEXAMETHYLENEBIS[5-(PCHLOROPHENYL) BIGUANIDE]DIHYDROCHLORIDE)Active2020-02-03
- POVIDONE-IODINE USP (1-VINYL-2-PYRROLIDINONE POLYMER, COMPOUND WITH IODINE)Active2020-02-03
- CHLORHEXIDINE BASE (1,1'-HEXAMETHYLENEBIS[5-(4-CHLOROPHENYL) BIGUANIDE])Active2020-02-03
- N-octyl-1-[10-(4-octyliminopyridin-1-yl) decyl] pyridin-4-imine dihydrochloride (Octenidine Dihydrochloride)Active2019-12-11
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to RN LABORATORIES EUROPE BV in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this RN LABORATORIES EUROPE BV? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.